Your browser doesn't support javascript.
loading
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene.
Roberts, Melyssa S; Anstine, Lindsey J; Finke, Viviane S; Bryson, Benjamin L; Webb, Bryan M; Weber-Bonk, Kristen L; Seachrist, Darcie D; Majmudar, Parth R; Keri, Ruth A.
Afiliación
  • Roberts MS; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Anstine LJ; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Finke VS; Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Bryson BL; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Webb BM; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Weber-Bonk KL; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Seachrist DD; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Majmudar PR; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Keri RA; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA. keri@case.edu.
Breast Cancer Res ; 22(1): 66, 2020 06 18.
Article en En | MEDLINE | ID: mdl-32552913
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción de Tipo Kruppel / Neoplasias de la Mama Triple Negativas / Clorhidrato de Erlotinib / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción de Tipo Kruppel / Neoplasias de la Mama Triple Negativas / Clorhidrato de Erlotinib / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido